Halozyme Therapeutics (HALO) - Management Comments

Halozyme Therapeutics (HALO) – Management Comments

May 10, 2021 04:57 PM Halozyme Therapeutics (HALO) Tops Q1 EPS by 5c, Revenues Beat; Offers FY21 EPS Mid-Point Guidance Above Consensus, FY21 Revs. Mid-Point Views Below Consensus
Jan 11, 2021 09:14 AM Halozyme Therapeutics (HALO) Reports Prelim. FY21 Revenue Guidance
Dec 23, 2020 06:19 AM
Nov 12, 2020 08:19 AM
Jun 29, 2020 01:02 PM
Jun 15, 2020 05:58 AM
May 1, 2020 03:17 PM
Apr 30, 2020 05:09 PM
Feb 24, 2020 04:23 PM
Jan 14, 2020 08:07 AM
Nov 4, 2019 07:03 AM
Sep 13, 2019 05:52 AM
Aug 6, 2019 06:03 PM
Jul 19, 2019 07:02 AM
Jul 17, 2019 08:01 AM
Jun 25, 2019 08:07 AM
Feb 28, 2019 11:49 AM
Feb 4, 2019 05:58 AM
Oct 30, 2018 08:23 AM
Oct 25, 2018 08:15 AM
Oct 22, 2018 08:11 AM
Oct 4, 2018 09:14 AM
Sep 17, 2018 08:04 AM
Sep 10, 2018 08:07 AM
Jul 26, 2018 08:20 AM
Jul 11, 2018 08:31 AM
Mar 14, 2018 05:45 PM
Dec 7, 2017 06:31 AM
Oct 24, 2017 08:31 AM
Oct 16, 2017 08:04 AM
Sep 14, 2017 07:00 AM
Jun 28, 2017 12:01 PM
Jun 22, 2017 03:18 PM
May 17, 2017 05:32 PM
Apr 3, 2017 08:02 AM
Mar 30, 2017 08:36 AM
Mar 29, 2017 12:46 PM
Feb 13, 2017 08:37 AM
Nov 3, 2016 09:06 AM
Oct 4, 2016 06:34 AM
Sep 16, 2016 07:45 AM
Sep 1, 2016 09:01 AM
Jul 26, 2016 09:05 AM
Apr 18, 2016 04:02 PM
Mar 16, 2016 08:35 AM
Jan 21, 2016 08:37 AM
Dec 21, 2015 08:31 AM
Dec 9, 2015 08:32 AM
Jun 5, 2015 09:01 AM
Jun 3, 2015 08:31 AM